Search Results
Mar 10, 2026, 17:31 ET CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
Obexelimab stands apart from other B-cell–directed treatments and shows promise for a wide range of autoimmune conditions. It is currently in Phase III trials for Warm Autoimmune Hemolytic Anemia and IgG4-Related Disease, and is also being explored for Multiple Sclerosis and Systemic Lupus Erythematosus.Galapagos'
More news about: DelveInsight Business Research, LLP
Mar 10, 2026, 16:05 ET Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditures for such replacements or for new capital expenditure requirements; (iii) Adjusted EBITDA also does not reflect changes in, or cash requirements for, our working capital needs or the potentially dilutive impact of stock-based
More news about: Shoulder Innovations
Mar 10, 2026, 16:00 ET First Mining Closes Sale of Cameron Gold Project to Seva Mining
to, statements with respect to (i) the potential benefits to be derived from the Transaction; (ii) First Mining's ownership percentage in Seva; and (iii) First Mining's plans related to its Springpole, Duparquet and other projects. All forward-looking statements are based on First Mining's or its consultants'
More news about: First Mining Gold Corp.
Mar 10, 2026, 15:37 ET /C O R R E C T I O N -- Ridgewood Infrastructure/
der gesamten Plattform unterstützen."„Diese Partnerschaft mit Ridgewood ist ein wichtiger nächster Schritt für Sierra", sagte Kennan H. Beard III, Chief Executive Officer von Sierra Northern. „Die Erfahrung von Ridgewood beim Betrieb von Eisenbahn- und Infrastrukturunternehmen in Verbindung mit
More news about: Ridgewood Infrastructure
Mar 10, 2026, 15:00 ET EQT Commences Tender Offer for Certain Senior Notes Up to $1.15 Billion Aggregate Purchase Price
applicable law, to (i) waive or modify, in whole or in part, any or all conditions of the Tender Offer, (ii) extend, terminate or withdraw the Tender Offer, (iii) increase or decrease the Aggregate Offer Cap or either or both Offer SubCaps or (iv) otherwise amend the Tender Offer in any respect.The purpose
More news about: EQT Corporation (EQT-IR)
Mar 10, 2026, 13:00 ET /C O R R E C T I O N -- Ridgewood Infrastructure/
and supporting innovation across the platform.""This partnership with Ridgewood marks an important next step for Sierra," said Kennan H. Beard III, Chief Executive Officer of Sierra Northern. "Ridgewood's experience operating rail and infrastructure businesses, combined with their investment approach,
More news about: Ridgewood Infrastructure
Mar 10, 2026, 12:25 ET /C O R R E C T I O N -- Ridgewood Infrastructure/
and supporting innovation across the platform.""This partnership with Ridgewood marks an important next step for Sierra," said Kennan H. Beard III, Chief Executive Officer of Sierra Northern. "Ridgewood's experience operating rail and infrastructure businesses, combined with their investment approach,
More news about: Ridgewood Infrastructure
Mar 10, 2026, 11:30 ET Jacobio Announces 2025 Annual Results
included in the National Reimbursement Drug List. From June to December 2025, Jacobio recognized revenue of RMB 8.55 million.A registrational Phase III trial evaluating glecirasib in combination with the SHP2 inhibitor sitneprotafib for the first-line treatment of non-small cell lung cancer is ongoing
More news about: Jacobio Pharma
Mar 10, 2026, 10:25 ET Neue Vitalität, neuer Schwung: Xi'ans Wirtschaftsbilanz 2025 und künftige Wachstumsaussichten
einer bestimmten Größe.Umgestaltung der Stadtentwicklung - Durchführung von 331 Stadterneuerungsprojekten, einschließlich der Phase III des Flughafens und der Hochgeschwindigkeitsstrecke Xi'an-Shiyan.Vertiefung der Reformen - Förderung zonenspezifischer Maßnahmen in Entwicklungsgebieten
More news about: Xi'an Municipal Government
Mar 10, 2026, 10:24 ET Nouvelle vitalité, nouvel élan : Examen de l'économie de Xi'an à l'horizon 2025 et perspectives de croissance future
au-dessus de la taille désignée.Transformer le développement urbain - mettre en œuvre 331 projets de rénovation urbaine, y compris la phase III de l'aéroport et la ligne ferroviaire à grande vitesse Xi'an-Shiyan.Approfondir les réformes - promouvoir des politiques spécifiques
More news about: Xi'an Municipal Government
Mar 10, 2026, 10:22 ET Nueva vitalidad, nuevo impulso: Análisis económico de Xi'an para 2025 y perspectivas de crecimiento futuro
3.000 empresas de alta tecnología.Transformar el desarrollo urbano: implementar 331 proyectos de renovación urbana, incluyendo la Fase III del aeropuerto y el ferrocarril de alta velocidad Xi'an-Shiyan.Profundizar las reformas: promover políticas zonales en las zonas de desarrollo
More news about: Xi'an Municipal Government
Mar 10, 2026, 10:18 ET Nova vitalidade, novo impulso: a revisão econômica de Xi'an em 2025 e as perspectivas de crescimento futuro
tecnologia acima do tamanho designado.Transformar o desenvolvimento urbano – implementar 331 projetos de renovação urbana, incluindo a Fase III do aeroporto e a Ferrovia de Alta Velocidade Xi 'an-Shiyan.Aprofundar as reformas – promover políticas específicas da zona em áreas de
More news about: Xi'an Municipal Government
Mar 10, 2026, 10:16 ET Nueva vitalidad, nuevo impulso: Revisión económica 2025 de Xi'an y perspectivas de crecimiento futuro
por encima del tamaño designado.Transformar el desarrollo urbano: implementar 331 proyectos de renovación urbana, incluyendo la Fase III del aeropuerto y el Ferrocarril de Alta Velocidad Xi 'an-Shiyan.Profundizar las reformas: promover políticas específicas de la zona en
More news about: Xi'an Municipal Government
Mar 10, 2026, 10:10 ET NuScale Power Corporation (SMR) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action filed by Robbins Geller Rudman & Dowd LLP
of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (iii) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience
More news about: Robbins Geller Rudman & Dowd LLP
Mar 10, 2026, 10:00 ET Integrity Partnership Accelerates Impact for MG3 Enterprises Offering Proprietary Technology Platform
today announced it has partnered with MG3 Enterprises, an independent marketing organization based in Charlotte, North Carolina, and led by Max Graham III. Financial details of the partnership were not disclosed.
More news about: Integrity Marketing Group, LLC
Mar 10, 2026, 09:19 ET AMTD Reached Deals on the Acquisition of a London Office Tower, in Conjunction with Amendment to Terms of Acquisition of the London Hornsey Town Hall Project, with Total Transaction Value at US$87.7 Million
East Consortium International Limited (0035.HK) (the "Horney Transactions", and collectively with the Office Transaction, the "Transactions"); and (iii) the terms of the Hornsey Transactions as previously agreed shall be amended to be in line with the terms of the Term Sheet including in respect of the
More news about: AMTD Digital; AMTD IDEA Group; The Generation Essentials Group
Mar 10, 2026, 09:02 ET Registrational Phase III AMPLIFY trial: Target number of participants achieved
company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Phase III AMPLIFY trial (NCT06970847)[1] has now consented in excess of the planned number of participants following strong demand for study participation
More news about: Clarity Pharmaceuticals
Mar 10, 2026, 09:00 ET Imre selects Fred Hickman III as EVP to lead Account Services
/PRNewswire/ -- Imre, a performance-driven creative agency specializing in healthcare and life sciences, today announced the appointment of Fred Hickman III as Executive Vice President, Group Account Lead, where he will lead the agency's Account Services department.
More news about: Imre
Mar 10, 2026, 09:00 ET Investors who lost money on Ultragenyx Pharmaceutical Inc.(RARE) should contact The Gross Law Firm about pending Class Action - RARE
decrease in annualized fracture rates or otherwise the Phase III Orbit and Cosmic studies were much less likely to be able to demonstrate such a link than management claimed. On December 29, 2025, Ultragenyx announced that both its Phase III Orbit and Cosmic Studies had not "achieved statistical significance
More news about: The Gross Law Firm
Mar 10, 2026, 09:00 ET As AI and Screen Time Scrutiny Rise, Instructure's 2026 Evidence Report Finds Most Classroom Consumer Technology Lacks Verified Proof of Impact
Among purpose-built edtech tools with ESSA-aligned evidence, 2% meet the strongest evidence standard (Level I). Another 5% meet Level II, 14% meet Level III and 19% meet Level IV standards.Privacy protections remain inconsistent across classroom technology: Purpose-built edtech products are
More news about: Instructure
Mar 10, 2026, 09:00 ET Class Action Filed Against Enphase Energy, Inc. (ENPH) - April 20, 2026 Deadline to Join - Contact The Gross Law Firm
its ability to manage its channel inventory; (ii) Enphase overstated its ability to mitigate effects arising from the termination of the 25D Credit; (iii) accordingly, Enphase overstated its financial and operational prospects; and (iv) as a result, the Company's public statements were materially false
More news about: The Gross Law Firm
Mar 10, 2026, 09:00 ET The Gross Law Firm Notifies Shareholders of Beyond Meat, Inc.(BYND) of a Class Action Lawsuit and an Upcoming Deadline
material, non-cash impairment charge; (ii) the foregoing was likely to impair Beyond Meat's ability to timely file its periodic filings with the SEC; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: March 24, 2026 Shareholders
More news about: The Gross Law Firm
Mar 10, 2026, 09:00 ET Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO
device was deficient; (ii) accordingly, Inovio was unlikely to submit it's lead product candidate, INO-3107 BLA to the FDA by the second half of 2024; (iii) Inovio had insufficient information to justify the INO-3107 BLA's eligibility for FDA accelerated approval or priority review; (iv) accordingly, INO-3107's
More news about: The Gross Law Firm
Mar 10, 2026, 09:00 ET CoreWeave, Inc. Class Action: The Gross Law Firm Reminds CoreWeave, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 13, 2026 - CRWV
that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; (iii) the foregoing was reasonably likely to have a material negative impact on the Company's revenue; (iv) as a result, the Company's public statements were
More news about: The Gross Law Firm
Mar 10, 2026, 09:00 ET The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 3, 2026 in Plug Power Lawsuit - PLUG
facilities necessary to receive those funds; (ii) as such, Plug Power was likely to pivot toward more modest projects with less commercial upside; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.DEADLINE: April 3, 2026 Shareholders
More news about: The Gross Law Firm